Polymarket market

Polymarket FDA moves BPC-157 to Category 1 odds

On Polymarket, the busiest line, December 31, 2026, is at 45%. The market settles by Dec 31, 2026. Each contract pays $1 if it is right, so 45¢ reads as a 45% chance. We have not matched it to a Kalshi market yet, so there is no second price.

Trade on Polymarket

Polymarket · odds · updated

December 31, 202645%
August 31, 20260%
–
24h volume on Polymarket
$5K
total volume on Polymarket
1
open of 2 outcomes
Dec 31, 2026
settles

Polymarket odds on every outcome

Polymarket odds on each outcome of FDA moves BPC-157 to Category 1
OutcomeChanceYes price24h volume
December 31, 202645%45¢$0Trade
August 31, 2026Final0%0¢$0

Chance is each outcome's Yes price on Polymarket. A Yes contract at 45¢ pays $1 if that outcome wins.

How the odds have moved

Polymarket · December 31, 2026
45%▼ 4.0 pts since Sep 28
Yes price
Sep 2842% – 55% scaleOct 5

Polymarket's own series for the outcome the headline prices, from where its history starts; one venue, not a blend.

How this market resolves

Polymarket's own settlement wording, in full. This, not the headline, decides who gets paid.

Show the full rules

This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET. Otherwise, this market will resolve to “No”.

A qualifying announcement must be official and public. Any rumored or private statements of intention will not qualify.

Any announcement that the drug has been reclassified to Category 1 will qualify. Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date.

A qualifying reclassification must be to Category 1 of the Bulk Drug Substances List or an equivalent classification that allows interim compounding of the drug. Removal from a different category will not qualify.

The resolution source for this market will be official statements from the FDA; however, a consensus of credible reporting will also be used.

Scheduled resolution: Dec 31, 2026.

How to trade this market on Polymarket

  1. Check your state first. A few states restrict some contracts.
  2. Open a Polymarket account. Americans trade on Polymarket US. Our Polymarket review covers sign-up and payouts.
  3. Buy Yes or No at the price shown, 45¢ for December 31, 2026 right now. Each contract pays $1 if you are right.
  4. Sell any time before it settles, or hold to the result. Polymarket's fees apply to each trade.

CoinStats may earn a commission on links to venues. Prices are indicative and may differ when you trade.

Not on Kalshi here yet: we have not matched this question to a Kalshi market, so there is no second price to compare. Kalshi vs Polymarket compares the two venues.

Common questions

What are the Polymarket odds on FDA moves BPC-157 to Category 1?

On Polymarket, the busiest line, December 31, 2026, is at 45%. That is a market-implied probability, not a forecast, and it moves as traders buy and sell.

How does this market resolve?

By Polymarket's own settlement rules for this market. Two venues can word the same question differently and settle differently, so read them before you trade.

Is this question on Kalshi too?

We have not matched it to a Kalshi market yet. When we do, both prices appear side by side here.

Can I trade this market in my state?

In most states, yes, on Polymarket US. A few states have acted against some contracts. Check your state first.

How accurate are Polymarket odds?

Often more accurate than polls, though never certain. A price of 70% should lose three times in ten. How accurate prediction markets are has the research.

What does it cost to trade on Polymarket?

A taker fee on most markets, largest near 50¢, and some categories charge nothing. Polymarket's fees has the detail.